0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Global and China Cancer Vaccine Market Insights, Forecast to 2026
Published Date: September 2020
|
Report Code: QYRE-Auto-28B3200
Home | Category |Health |Health Conditions |Cancer
Global and China Cancer Vaccine Market Insights Forecast to 2026

Global and China Cancer Vaccine Market Insights, Forecast to 2026

Code: QYRE-Auto-28B3200
Report
September 2020
129 Pages
QYResearch
Region: Global, Taiwan, China, Africa, Germany, Canada, France, Japan, Indonesia, Malaysia, Australia, Thailand, India, South Korea, Italy, Saudi Arabia, Philippines, Brazil, Turkey, Vietnam, Mexico,
Description
Table of Content
Tables & Figures
Cancer Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Cancer Vaccine market is segmented into
    Preventive vaccines
    Therapeutic vaccines
Segment by Application, the Cancer Vaccine market is segmented into
    Prostate Cancer
    Cervical Cancer
    Others
Regional and Country-level Analysis
The Cancer Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cancer Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Vaccine Market Share Analysis
Cancer Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Vaccine business, the date to enter into the Cancer Vaccine market, Cancer Vaccine product introduction, recent developments, etc.
The major vendors covered:
    Dendreon Corporation
    NeoStem Oncology
    ImmunoGen
    Inovio Pharmaceuticals
    Novartis
    ...
1 Study Coverage
1.1 Cancer Vaccine Product Introduction
1.2 Market Segments
1.3 Key Cancer Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cancer Vaccine Market Size Growth Rate by Type
1.4.2 Preventive vaccines
1.4.3 Therapeutic vaccines
1.5 Market by Application
1.5.1 Global Cancer Vaccine Market Size Growth Rate by Application
1.5.2 Prostate Cancer
1.5.3 Cervical Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Cancer Vaccine Revenue 2015-2026
2.1.2 Global Cancer Vaccine Sales 2015-2026
2.2 Global Cancer Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Cancer Vaccine Historical Market Size by Region (2015-2020)
2.3.1 Global Cancer Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Cancer Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Cancer Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Cancer Vaccine Sales Forecast by Region (2021-2026)
2.4.2 Global Cancer Vaccine Revenue Forecast by Region (2021-2026)
3 Global Cancer Vaccine Competitor Landscape by Players
3.1 Global Top Cancer Vaccine Sales by Manufacturers
3.1.1 Global Cancer Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Cancer Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Cancer Vaccine Manufacturers by Revenue
3.2.1 Global Cancer Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Cancer Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cancer Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cancer Vaccine Revenue in 2019
3.2.5 Global Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cancer Vaccine Price by Manufacturers
3.4 Global Cancer Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Cancer Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Vaccine Market Size by Type (2015-2020)
4.1.1 Global Cancer Vaccine Sales by Type (2015-2020)
4.1.2 Global Cancer Vaccine Revenue by Type (2015-2020)
4.1.3 Cancer Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cancer Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Cancer Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Cancer Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cancer Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cancer Vaccine Market Size by Application (2015-2020)
5.1.1 Global Cancer Vaccine Sales by Application (2015-2020)
5.1.2 Global Cancer Vaccine Revenue by Application (2015-2020)
5.1.3 Cancer Vaccine Price by Application (2015-2020)
5.2 Cancer Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Cancer Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Vaccine Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Cancer Vaccine Market Size YoY Growth 2015-2026
6.1.1 China Cancer Vaccine Sales YoY Growth 2015-2026
6.1.2 China Cancer Vaccine Revenue YoY Growth 2015-2026
6.1.3 China Cancer Vaccine Market Share in Global Market 2015-2026
6.2 China Cancer Vaccine Market Size by Players (International and Local Players)
6.2.1 China Top Cancer Vaccine Players by Sales (2015-2020)
6.2.2 China Top Cancer Vaccine Players by Revenue (2015-2020)
6.3 China Cancer Vaccine Historic Market Review by Type (2015-2020)
6.3.1 China Cancer Vaccine Sales Market Share by Type (2015-2020)
6.3.2 China Cancer Vaccine Revenue Market Share by Type (2015-2020)
6.3.3 China Cancer Vaccine Price by Type (2015-2020)
6.4 China Cancer Vaccine Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Cancer Vaccine Sales Forecast by Type (2021-2026)
6.4.2 China Cancer Vaccine Revenue Forecast by Type (2021-2026)
6.4.3 China Cancer Vaccine Price Forecast by Type (2021-2026)
6.5 China Cancer Vaccine Historic Market Review by Application (2015-2020)
6.5.1 China Cancer Vaccine Sales Market Share by Application (2015-2020)
6.5.2 China Cancer Vaccine Revenue Market Share by Application (2015-2020)
6.5.3 China Cancer Vaccine Price by Application (2015-2020)
6.6 China Cancer Vaccine Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Cancer Vaccine Sales Forecast by Application (2021-2026)
6.6.2 China Cancer Vaccine Revenue Forecast by Application (2021-2026)
6.6.3 China Cancer Vaccine Price Forecast by Application (2021-2026)
7 North America
7.1 North America Cancer Vaccine Market Size YoY Growth 2015-2026
7.2 North America Cancer Vaccine Market Facts & Figures by Country
7.2.1 North America Cancer Vaccine Sales by Country (2015-2020)
7.2.2 North America Cancer Vaccine Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Cancer Vaccine Market Size YoY Growth 2015-2026
8.2 Europe Cancer Vaccine Market Facts & Figures by Country
8.2.1 Europe Cancer Vaccine Sales by Country
8.2.2 Europe Cancer Vaccine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Cancer Vaccine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Cancer Vaccine Market Facts & Figures by Country
9.2.1 Asia Pacific Cancer Vaccine Sales by Region (2015-2020)
9.2.2 Asia Pacific Cancer Vaccine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Cancer Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Cancer Vaccine Market Facts & Figures by Country
10.2.1 Latin America Cancer Vaccine Sales by Country
10.2.2 Latin America Cancer Vaccine Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Cancer Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Cancer Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Cancer Vaccine Sales by Country
11.2.2 Middle East and Africa Cancer Vaccine Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Dendreon Corporation
12.1.1 Dendreon Corporation Corporation Information
12.1.2 Dendreon Corporation Description and Business Overview
12.1.3 Dendreon Corporation Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Dendreon Corporation Cancer Vaccine Products Offered
12.1.5 Dendreon Corporation Recent Development
12.2 NeoStem Oncology
12.2.1 NeoStem Oncology Corporation Information
12.2.2 NeoStem Oncology Description and Business Overview
12.2.3 NeoStem Oncology Sales, Revenue and Gross Margin (2015-2020)
12.2.4 NeoStem Oncology Cancer Vaccine Products Offered
12.2.5 NeoStem Oncology Recent Development
12.3 ImmunoGen
12.3.1 ImmunoGen Corporation Information
12.3.2 ImmunoGen Description and Business Overview
12.3.3 ImmunoGen Sales, Revenue and Gross Margin (2015-2020)
12.3.4 ImmunoGen Cancer Vaccine Products Offered
12.3.5 ImmunoGen Recent Development
12.4 Inovio Pharmaceuticals
12.4.1 Inovio Pharmaceuticals Corporation Information
12.4.2 Inovio Pharmaceuticals Description and Business Overview
12.4.3 Inovio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Inovio Pharmaceuticals Cancer Vaccine Products Offered
12.4.5 Inovio Pharmaceuticals Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Description and Business Overview
12.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Cancer Vaccine Products Offered
12.5.5 Novartis Recent Development
12.11 Dendreon Corporation
12.11.1 Dendreon Corporation Corporation Information
12.11.2 Dendreon Corporation Description and Business Overview
12.11.3 Dendreon Corporation Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Dendreon Corporation Cancer Vaccine Products Offered
12.11.5 Dendreon Corporation Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cancer Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Cancer Vaccine Market Segments
    Table 2. Ranking of Global Top Cancer Vaccine Manufacturers by Revenue (US$ Million) in 2019
    Table 3. Global Cancer Vaccine Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
    Table 4. Major Manufacturers of Preventive vaccines
    Table 5. Major Manufacturers of Therapeutic vaccines
    Table 6. Global Cancer Vaccine Market Size Growth Rate by Application 2020-2026 (MT)
    Table 7. Global Cancer Vaccine Market Size by Region (MT) & (US$ Million): 2020 VS 2026
    Table 8. Global Cancer Vaccine Sales by Regions 2015-2020 (MT)
    Table 9. Global Cancer Vaccine Sales Market Share by Regions (2015-2020)
    Table 10. Global Cancer Vaccine Revenue by Regions 2015-2020 (US$ Million)
    Table 11. Global Cancer Vaccine Sales Forecast by Region (2021-2026) (MT)
    Table 12. Global Cancer Vaccine Sales by Manufacturers (2015-2020) (MT)
    Table 13. Global Cancer Vaccine Sales Share by Manufacturers (2015-2020)
    Table 14. Global Cancer Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
    Table 15. Global Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Vaccine as of 2019)
    Table 16. Cancer Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
    Table 17. Cancer Vaccine Revenue Share by Manufacturers (2015-2020)
    Table 18. Key Manufacturers Cancer Vaccine Price (2015-2020) (USD/MT)
    Table 19. Cancer Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 20. Manufacturers Cancer Vaccine Product Type
    Table 21. Date of International Manufacturers Enter into Cancer Vaccine Market
    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 23. Global Cancer Vaccine Sales by Type (2015-2020) (MT)
    Table 24. Global Cancer Vaccine Sales Share by Type (2015-2020)
    Table 25. Global Cancer Vaccine Revenue by Type (2015-2020) (US$ Million)
    Table 26. Global Cancer Vaccine Revenue Share by Type (2015-2020)
    Table 27. Cancer Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
    Table 28. Global Cancer Vaccine Sales Share by Type (2021-2026)
    Table 29. Global Cancer Vaccine Sales by Application (2015-2020) (MT)
    Table 30. Global Cancer Vaccine Sales Share by Application (2015-2020)
    Table 31. Global Cancer Vaccine Sales Share by Application (2021-2026)
    Table 32. Global Cancer Vaccine Sales Market Share Forecast by Application (2021-2026)
    Table 33. Global Cancer Vaccine Revenue by Application (2015-2020) (US$ Million)
    Table 34. Global Cancer Vaccine Revenue Market Share Forecast by Application (2021-2026)
    Table 35. China Cancer Vaccine Sales (MT) of Key Companies (2015-2020)
    Table 36. China Cancer Vaccine Sales Share by Company (2015-2020)
    Table 37. China Cancer Vaccine Revenue (US$ Million) by Company (2015-2020)
    Table 38. China Cancer Vaccine Sales (MT) by Type (2015-2020)
    Table 39. China Cancer Vaccine Sales Share by Type (2015-2020)
    Table 40. China Cancer Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
    Table 41. China Cancer Vaccine Price (MT) by Type (2015-2020)
    Table 42. China Cancer Vaccine Sales (MT) by Type (2021-2026)
    Table 43. China Cancer Vaccine Sales Share by Type (2021-2026)
    Table 44. China Cancer Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
    Table 45. China Cancer Vaccine Revenue Share by Type (2021-2026)
    Table 46. China Cancer Vaccine Price (MT) by Type (2021-2026)
    Table 47. China Cancer Vaccine Sales (MT) by Application (2015-2020)
    Table 48. China Cancer Vaccine Sales Share by Application (2015-2020)
    Table 49. China Cancer Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
    Table 50. China Cancer Vaccine Sales (MT) by Application (2021-2026)
    Table 51. China Cancer Vaccine Sales Share by Application (2021-2026)
    Table 52. China Cancer Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
    Table 53. China Cancer Vaccine Revenue Share by Application (2021-2026)
    Table 54. North America Cancer Vaccine Sales by Country (2015-2020) (MT)
    Table 55. North America Cancer Vaccine Sales Market Share by Country (2015-2020)
    Table 56. North America Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 57. North America Cancer Vaccine Revenue Market Share by Country (2015-2020)
    Table 58. Europe Cancer Vaccine Sales by Country (2015-2020) (MT)
    Table 59. Europe Cancer Vaccine Sales Market Share by Country (2015-2020)
    Table 60. Europe Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 61. Europe Cancer Vaccine Revenue Market Share by Country (2015-2020)
    Table 62. Asia Pacific Cancer Vaccine Sales by Region (2015-2020) (MT)
    Table 63. Asia Pacific Cancer Vaccine Sales Market Share by Region (2015-2020)
    Table 64. Asia Pacific Cancer Vaccine Revenue by Region (2015-2020) (US$ Million)
    Table 65. Asia Pacific Cancer Vaccine Revenue Market Share by Region (2015-2020)
    Table 66. Latin America Cancer Vaccine Sales by Country (2015-2020) (MT)
    Table 67. Latin America Cancer Vaccine Sales Market Share by Country (2015-2020)
    Table 68. Latin Americaa Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 69. Latin America Cancer Vaccine Revenue Market Share by Country (2015-2020)
    Table 70. Middle East and Africa Cancer Vaccine Sales by Country (2015-2020) (MT)
    Table 71. Middle East and Africa Cancer Vaccine Sales Market Share by Country (2015-2020)
    Table 72. Middle East and Africa Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 73. Middle East and Africa Cancer Vaccine Revenue Market Share by Country (2015-2020)
    Table 74. Dendreon Corporation Corporation Information
    Table 75. Dendreon Corporation Description and Business Overview
    Table 76. Dendreon Corporation Cancer Vaccine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 77. Dendreon Corporation Cancer Vaccine Product
    Table 78. Dendreon Corporation Recent Development
    Table 79. NeoStem Oncology Corporation Information
    Table 80. NeoStem Oncology Description and Business Overview
    Table 81. NeoStem Oncology Cancer Vaccine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 82. NeoStem Oncology Product
    Table 83. NeoStem Oncology Recent Development
    Table 84. ImmunoGen Corporation Information
    Table 85. ImmunoGen Description and Business Overview
    Table 86. ImmunoGen Cancer Vaccine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 87. ImmunoGen Product
    Table 88. ImmunoGen Recent Development
    Table 89. Inovio Pharmaceuticals Corporation Information
    Table 90. Inovio Pharmaceuticals Description and Business Overview
    Table 91. Inovio Pharmaceuticals Cancer Vaccine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 92. Inovio Pharmaceuticals Product
    Table 93. Inovio Pharmaceuticals Recent Development
    Table 94. Novartis Corporation Information
    Table 95. Novartis Description and Business Overview
    Table 96. Novartis Cancer Vaccine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 97. Novartis Product
    Table 98. Novartis Recent Development
    Table 99. Key Opportunities and Drivers: Impact Analysis (2021-2026)
    Table 100. Key Challenges
    Table 101. Market Risks
    Table 102. Main Points Interviewed from Key Cancer Vaccine Players
    Table 103. Cancer Vaccine Customers List
    Table 104. Cancer Vaccine Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cancer Vaccine Product Picture
    Figure 2. Global Cancer Vaccine Sales Market Share by Type in 2020 & 2026
    Figure 3. Preventive vaccines Product Picture
    Figure 4. Therapeutic vaccines Product Picture
    Figure 5. Global Cancer Vaccine Sales Market Share by Application in 2020 & 2026
    Figure 6. Prostate Cancer
    Figure 7. Cervical Cancer
    Figure 8. Others
    Figure 9. Cancer Vaccine Report Years Considered
    Figure 10. Global Cancer Vaccine Market Size 2015-2026 (US$ Million)
    Figure 11. Global Cancer Vaccine Sales 2015-2026 (MT)
    Figure 12. Global Cancer Vaccine Market Size Market Share by Region: 2020 Versus 2026
    Figure 13. Global Cancer Vaccine Sales Market Share by Region (2015-2020)
    Figure 14. Global Cancer Vaccine Sales Market Share by Region in 2019
    Figure 15. Global Cancer Vaccine Revenue Market Share by Region (2015-2020)
    Figure 16. Global Cancer Vaccine Revenue Market Share by Region in 2019
    Figure 17. Global Cancer Vaccine Sales Share by Manufacturer in 2019
    Figure 18. The Top 10 and 5 Players Market Share by Cancer Vaccine Revenue in 2019
    Figure 19. Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
    Figure 20. Global Cancer Vaccine Sales Market Share by Type (2015-2020)
    Figure 21. Global Cancer Vaccine Sales Market Share by Type in 2019
    Figure 22. Global Cancer Vaccine Revenue Market Share by Type (2015-2020)
    Figure 23. Global Cancer Vaccine Revenue Market Share by Type in 2019
    Figure 24. Global Cancer Vaccine Market Share by Price Range (2015-2020)
    Figure 25. Global Cancer Vaccine Sales Market Share by Application (2015-2020)
    Figure 26. Global Cancer Vaccine Sales Market Share by Application in 2019
    Figure 27. Global Cancer Vaccine Revenue Market Share by Application (2015-2020)
    Figure 28. Global Cancer Vaccine Revenue Market Share by Application in 2019
    Figure 29. China Cancer Vaccine Sales Growth Rate 2015-2026 (MT)
    Figure 30. China Cancer Vaccine Revenue Growth Rate 2015-2026 (US$ Million)
    Figure 31. China Cancer Vaccine Market Share in Global Market 2015-2026
    Figure 32. China 5 and 10 Largest Cancer Vaccine Players Market Share by Revenue in Cancer Vaccine in 2019
    Figure 33. China Cancer Vaccine Revenue Share by Type (2015-2020)
    Figure 34. China Cancer Vaccine Revenue Growth Rate by Type in 2015 & 2019
    Figure 35. China Cancer Vaccine Revenue Share by Application (2015-2020)
    Figure 36. China Cancer Vaccine Revenue Growth Rate by Application in 2015 & 2019
    Figure 37. North America Cancer Vaccine Sales Growth Rate 2015-2020 (MT)
    Figure 38. North America Cancer Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 39. North America Cancer Vaccine Sales Market Share by Country in 2019
    Figure 40. North America Cancer Vaccine Revenue Market Share by Country in 2019
    Figure 41. U.S. Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 42. U.S. Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 43. Canada Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 44. Canada Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 45. Europe Cancer Vaccine Sales Growth Rate 2015-2020 (MT)
    Figure 46. Europe Cancer Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 47. Europe Cancer Vaccine Sales Market Share by Country in 2019
    Figure 48. Europe Cancer Vaccine Revenue Market Share by Country in 2019
    Figure 49. Germany Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 50. Germany Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 51. France Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 52. France Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 53. U.K. Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 54. U.K. Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 55. Italy Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 56. Italy Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 57. Russia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 58. Russia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 59. Asia Pacific Cancer Vaccine Sales Growth Rate 2015-2020 (MT)
    Figure 60. Asia Pacific Cancer Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 61. Asia Pacific Cancer Vaccine Sales Market Share by Region in 2019
    Figure 62. Asia Pacific Cancer Vaccine Revenue Market Share by Region in 2019
    Figure 63. China Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 64. China Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 65. Japan Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 66. Japan Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 67. South Korea Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 68. South Korea Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 69. India Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 70. India Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 71. Australia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 72. Australia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 73. Taiwan Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 74. Taiwan Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 75. Indonesia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 76. Indonesia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 77. Thailand Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 78. Thailand Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 79. Malaysia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 80. Malaysia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 81. Philippines Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 82. Philippines Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 83. Vietnam Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 84. Vietnam Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 85. Latin America Cancer Vaccine Sales Growth Rate 2015-2020 (MT)
    Figure 86. Latin America Cancer Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 87. Latin America Cancer Vaccine Sales Market Share by Country in 2019
    Figure 88. Latin America Cancer Vaccine Revenue Market Share by Country in 2019
    Figure 89. Mexico Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 90. Mexico Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 91. Brazil Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 92. Brazil Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 93. Argentina Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 94. Argentina Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 95. Middle East and Africa Cancer Vaccine Sales Growth Rate 2015-2020 (MT)
    Figure 96. Middle East and Africa Cancer Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 97. Middle East and Africa Cancer Vaccine Sales Market Share by Country in 2019
    Figure 98. Middle East and Africa Cancer Vaccine Revenue Market Share by Country in 2019
    Figure 99. Turkey Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 100. Turkey Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 101. Saudi Arabia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 102. Saudi Arabia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 103. U.A.E Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 104. U.A.E Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 105. Porter's Five Forces Analysis
    Figure 106. Cancer Vaccine Value Chain
    Figure 107. Channels of Distribution
    Figure 108. Distributors Profiles
    Figure 109. Bottom-up and Top-down Approaches for This Report
    Figure 110. Data Triangulation
    Figure 111. Key Executives Interviewed
Cancer Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Cancer Vaccine market is segmented into
    Preventive vaccines
    Therapeutic vaccines
Segment by Application, the Cancer Vaccine market is segmented into
    Prostate Cancer
    Cervical Cancer
    Others
Regional and Country-level Analysis
The Cancer Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cancer Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Vaccine Market Share Analysis
Cancer Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Vaccine business, the date to enter into the Cancer Vaccine market, Cancer Vaccine product introduction, recent developments, etc.
The major vendors covered:
    Dendreon Corporation
    NeoStem Oncology
    ImmunoGen
    Inovio Pharmaceuticals
    Novartis
    ...
Read More
1 Study Coverage
1.1 Cancer Vaccine Product Introduction
1.2 Market Segments
1.3 Key Cancer Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cancer Vaccine Market Size Growth Rate by Type
1.4.2 Preventive vaccines
1.4.3 Therapeutic vaccines
1.5 Market by Application
1.5.1 Global Cancer Vaccine Market Size Growth Rate by Application
1.5.2 Prostate Cancer
1.5.3 Cervical Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Cancer Vaccine Revenue 2015-2026
2.1.2 Global Cancer Vaccine Sales 2015-2026
2.2 Global Cancer Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Cancer Vaccine Historical Market Size by Region (2015-2020)
2.3.1 Global Cancer Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Cancer Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Cancer Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Cancer Vaccine Sales Forecast by Region (2021-2026)
2.4.2 Global Cancer Vaccine Revenue Forecast by Region (2021-2026)
3 Global Cancer Vaccine Competitor Landscape by Players
3.1 Global Top Cancer Vaccine Sales by Manufacturers
3.1.1 Global Cancer Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Cancer Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Cancer Vaccine Manufacturers by Revenue
3.2.1 Global Cancer Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Cancer Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cancer Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cancer Vaccine Revenue in 2019
3.2.5 Global Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cancer Vaccine Price by Manufacturers
3.4 Global Cancer Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Cancer Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Vaccine Market Size by Type (2015-2020)
4.1.1 Global Cancer Vaccine Sales by Type (2015-2020)
4.1.2 Global Cancer Vaccine Revenue by Type (2015-2020)
4.1.3 Cancer Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cancer Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Cancer Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Cancer Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cancer Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cancer Vaccine Market Size by Application (2015-2020)
5.1.1 Global Cancer Vaccine Sales by Application (2015-2020)
5.1.2 Global Cancer Vaccine Revenue by Application (2015-2020)
5.1.3 Cancer Vaccine Price by Application (2015-2020)
5.2 Cancer Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Cancer Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Vaccine Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Cancer Vaccine Market Size YoY Growth 2015-2026
6.1.1 China Cancer Vaccine Sales YoY Growth 2015-2026
6.1.2 China Cancer Vaccine Revenue YoY Growth 2015-2026
6.1.3 China Cancer Vaccine Market Share in Global Market 2015-2026
6.2 China Cancer Vaccine Market Size by Players (International and Local Players)
6.2.1 China Top Cancer Vaccine Players by Sales (2015-2020)
6.2.2 China Top Cancer Vaccine Players by Revenue (2015-2020)
6.3 China Cancer Vaccine Historic Market Review by Type (2015-2020)
6.3.1 China Cancer Vaccine Sales Market Share by Type (2015-2020)
6.3.2 China Cancer Vaccine Revenue Market Share by Type (2015-2020)
6.3.3 China Cancer Vaccine Price by Type (2015-2020)
6.4 China Cancer Vaccine Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Cancer Vaccine Sales Forecast by Type (2021-2026)
6.4.2 China Cancer Vaccine Revenue Forecast by Type (2021-2026)
6.4.3 China Cancer Vaccine Price Forecast by Type (2021-2026)
6.5 China Cancer Vaccine Historic Market Review by Application (2015-2020)
6.5.1 China Cancer Vaccine Sales Market Share by Application (2015-2020)
6.5.2 China Cancer Vaccine Revenue Market Share by Application (2015-2020)
6.5.3 China Cancer Vaccine Price by Application (2015-2020)
6.6 China Cancer Vaccine Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Cancer Vaccine Sales Forecast by Application (2021-2026)
6.6.2 China Cancer Vaccine Revenue Forecast by Application (2021-2026)
6.6.3 China Cancer Vaccine Price Forecast by Application (2021-2026)
7 North America
7.1 North America Cancer Vaccine Market Size YoY Growth 2015-2026
7.2 North America Cancer Vaccine Market Facts & Figures by Country
7.2.1 North America Cancer Vaccine Sales by Country (2015-2020)
7.2.2 North America Cancer Vaccine Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Cancer Vaccine Market Size YoY Growth 2015-2026
8.2 Europe Cancer Vaccine Market Facts & Figures by Country
8.2.1 Europe Cancer Vaccine Sales by Country
8.2.2 Europe Cancer Vaccine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Cancer Vaccine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Cancer Vaccine Market Facts & Figures by Country
9.2.1 Asia Pacific Cancer Vaccine Sales by Region (2015-2020)
9.2.2 Asia Pacific Cancer Vaccine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Cancer Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Cancer Vaccine Market Facts & Figures by Country
10.2.1 Latin America Cancer Vaccine Sales by Country
10.2.2 Latin America Cancer Vaccine Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Cancer Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Cancer Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Cancer Vaccine Sales by Country
11.2.2 Middle East and Africa Cancer Vaccine Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Dendreon Corporation
12.1.1 Dendreon Corporation Corporation Information
12.1.2 Dendreon Corporation Description and Business Overview
12.1.3 Dendreon Corporation Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Dendreon Corporation Cancer Vaccine Products Offered
12.1.5 Dendreon Corporation Recent Development
12.2 NeoStem Oncology
12.2.1 NeoStem Oncology Corporation Information
12.2.2 NeoStem Oncology Description and Business Overview
12.2.3 NeoStem Oncology Sales, Revenue and Gross Margin (2015-2020)
12.2.4 NeoStem Oncology Cancer Vaccine Products Offered
12.2.5 NeoStem Oncology Recent Development
12.3 ImmunoGen
12.3.1 ImmunoGen Corporation Information
12.3.2 ImmunoGen Description and Business Overview
12.3.3 ImmunoGen Sales, Revenue and Gross Margin (2015-2020)
12.3.4 ImmunoGen Cancer Vaccine Products Offered
12.3.5 ImmunoGen Recent Development
12.4 Inovio Pharmaceuticals
12.4.1 Inovio Pharmaceuticals Corporation Information
12.4.2 Inovio Pharmaceuticals Description and Business Overview
12.4.3 Inovio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Inovio Pharmaceuticals Cancer Vaccine Products Offered
12.4.5 Inovio Pharmaceuticals Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Description and Business Overview
12.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Cancer Vaccine Products Offered
12.5.5 Novartis Recent Development
12.11 Dendreon Corporation
12.11.1 Dendreon Corporation Corporation Information
12.11.2 Dendreon Corporation Description and Business Overview
12.11.3 Dendreon Corporation Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Dendreon Corporation Cancer Vaccine Products Offered
12.11.5 Dendreon Corporation Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cancer Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Read More
List of Tables
    Table 1. Cancer Vaccine Market Segments
    Table 2. Ranking of Global Top Cancer Vaccine Manufacturers by Revenue (US$ Million) in 2019
    Table 3. Global Cancer Vaccine Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
    Table 4. Major Manufacturers of Preventive vaccines
    Table 5. Major Manufacturers of Therapeutic vaccines
    Table 6. Global Cancer Vaccine Market Size Growth Rate by Application 2020-2026 (MT)
    Table 7. Global Cancer Vaccine Market Size by Region (MT) & (US$ Million): 2020 VS 2026
    Table 8. Global Cancer Vaccine Sales by Regions 2015-2020 (MT)
    Table 9. Global Cancer Vaccine Sales Market Share by Regions (2015-2020)
    Table 10. Global Cancer Vaccine Revenue by Regions 2015-2020 (US$ Million)
    Table 11. Global Cancer Vaccine Sales Forecast by Region (2021-2026) (MT)
    Table 12. Global Cancer Vaccine Sales by Manufacturers (2015-2020) (MT)
    Table 13. Global Cancer Vaccine Sales Share by Manufacturers (2015-2020)
    Table 14. Global Cancer Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
    Table 15. Global Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Vaccine as of 2019)
    Table 16. Cancer Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
    Table 17. Cancer Vaccine Revenue Share by Manufacturers (2015-2020)
    Table 18. Key Manufacturers Cancer Vaccine Price (2015-2020) (USD/MT)
    Table 19. Cancer Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 20. Manufacturers Cancer Vaccine Product Type
    Table 21. Date of International Manufacturers Enter into Cancer Vaccine Market
    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 23. Global Cancer Vaccine Sales by Type (2015-2020) (MT)
    Table 24. Global Cancer Vaccine Sales Share by Type (2015-2020)
    Table 25. Global Cancer Vaccine Revenue by Type (2015-2020) (US$ Million)
    Table 26. Global Cancer Vaccine Revenue Share by Type (2015-2020)
    Table 27. Cancer Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
    Table 28. Global Cancer Vaccine Sales Share by Type (2021-2026)
    Table 29. Global Cancer Vaccine Sales by Application (2015-2020) (MT)
    Table 30. Global Cancer Vaccine Sales Share by Application (2015-2020)
    Table 31. Global Cancer Vaccine Sales Share by Application (2021-2026)
    Table 32. Global Cancer Vaccine Sales Market Share Forecast by Application (2021-2026)
    Table 33. Global Cancer Vaccine Revenue by Application (2015-2020) (US$ Million)
    Table 34. Global Cancer Vaccine Revenue Market Share Forecast by Application (2021-2026)
    Table 35. China Cancer Vaccine Sales (MT) of Key Companies (2015-2020)
    Table 36. China Cancer Vaccine Sales Share by Company (2015-2020)
    Table 37. China Cancer Vaccine Revenue (US$ Million) by Company (2015-2020)
    Table 38. China Cancer Vaccine Sales (MT) by Type (2015-2020)
    Table 39. China Cancer Vaccine Sales Share by Type (2015-2020)
    Table 40. China Cancer Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
    Table 41. China Cancer Vaccine Price (MT) by Type (2015-2020)
    Table 42. China Cancer Vaccine Sales (MT) by Type (2021-2026)
    Table 43. China Cancer Vaccine Sales Share by Type (2021-2026)
    Table 44. China Cancer Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
    Table 45. China Cancer Vaccine Revenue Share by Type (2021-2026)
    Table 46. China Cancer Vaccine Price (MT) by Type (2021-2026)
    Table 47. China Cancer Vaccine Sales (MT) by Application (2015-2020)
    Table 48. China Cancer Vaccine Sales Share by Application (2015-2020)
    Table 49. China Cancer Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
    Table 50. China Cancer Vaccine Sales (MT) by Application (2021-2026)
    Table 51. China Cancer Vaccine Sales Share by Application (2021-2026)
    Table 52. China Cancer Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
    Table 53. China Cancer Vaccine Revenue Share by Application (2021-2026)
    Table 54. North America Cancer Vaccine Sales by Country (2015-2020) (MT)
    Table 55. North America Cancer Vaccine Sales Market Share by Country (2015-2020)
    Table 56. North America Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 57. North America Cancer Vaccine Revenue Market Share by Country (2015-2020)
    Table 58. Europe Cancer Vaccine Sales by Country (2015-2020) (MT)
    Table 59. Europe Cancer Vaccine Sales Market Share by Country (2015-2020)
    Table 60. Europe Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 61. Europe Cancer Vaccine Revenue Market Share by Country (2015-2020)
    Table 62. Asia Pacific Cancer Vaccine Sales by Region (2015-2020) (MT)
    Table 63. Asia Pacific Cancer Vaccine Sales Market Share by Region (2015-2020)
    Table 64. Asia Pacific Cancer Vaccine Revenue by Region (2015-2020) (US$ Million)
    Table 65. Asia Pacific Cancer Vaccine Revenue Market Share by Region (2015-2020)
    Table 66. Latin America Cancer Vaccine Sales by Country (2015-2020) (MT)
    Table 67. Latin America Cancer Vaccine Sales Market Share by Country (2015-2020)
    Table 68. Latin Americaa Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 69. Latin America Cancer Vaccine Revenue Market Share by Country (2015-2020)
    Table 70. Middle East and Africa Cancer Vaccine Sales by Country (2015-2020) (MT)
    Table 71. Middle East and Africa Cancer Vaccine Sales Market Share by Country (2015-2020)
    Table 72. Middle East and Africa Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 73. Middle East and Africa Cancer Vaccine Revenue Market Share by Country (2015-2020)
    Table 74. Dendreon Corporation Corporation Information
    Table 75. Dendreon Corporation Description and Business Overview
    Table 76. Dendreon Corporation Cancer Vaccine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 77. Dendreon Corporation Cancer Vaccine Product
    Table 78. Dendreon Corporation Recent Development
    Table 79. NeoStem Oncology Corporation Information
    Table 80. NeoStem Oncology Description and Business Overview
    Table 81. NeoStem Oncology Cancer Vaccine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 82. NeoStem Oncology Product
    Table 83. NeoStem Oncology Recent Development
    Table 84. ImmunoGen Corporation Information
    Table 85. ImmunoGen Description and Business Overview
    Table 86. ImmunoGen Cancer Vaccine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 87. ImmunoGen Product
    Table 88. ImmunoGen Recent Development
    Table 89. Inovio Pharmaceuticals Corporation Information
    Table 90. Inovio Pharmaceuticals Description and Business Overview
    Table 91. Inovio Pharmaceuticals Cancer Vaccine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 92. Inovio Pharmaceuticals Product
    Table 93. Inovio Pharmaceuticals Recent Development
    Table 94. Novartis Corporation Information
    Table 95. Novartis Description and Business Overview
    Table 96. Novartis Cancer Vaccine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
    Table 97. Novartis Product
    Table 98. Novartis Recent Development
    Table 99. Key Opportunities and Drivers: Impact Analysis (2021-2026)
    Table 100. Key Challenges
    Table 101. Market Risks
    Table 102. Main Points Interviewed from Key Cancer Vaccine Players
    Table 103. Cancer Vaccine Customers List
    Table 104. Cancer Vaccine Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cancer Vaccine Product Picture
    Figure 2. Global Cancer Vaccine Sales Market Share by Type in 2020 & 2026
    Figure 3. Preventive vaccines Product Picture
    Figure 4. Therapeutic vaccines Product Picture
    Figure 5. Global Cancer Vaccine Sales Market Share by Application in 2020 & 2026
    Figure 6. Prostate Cancer
    Figure 7. Cervical Cancer
    Figure 8. Others
    Figure 9. Cancer Vaccine Report Years Considered
    Figure 10. Global Cancer Vaccine Market Size 2015-2026 (US$ Million)
    Figure 11. Global Cancer Vaccine Sales 2015-2026 (MT)
    Figure 12. Global Cancer Vaccine Market Size Market Share by Region: 2020 Versus 2026
    Figure 13. Global Cancer Vaccine Sales Market Share by Region (2015-2020)
    Figure 14. Global Cancer Vaccine Sales Market Share by Region in 2019
    Figure 15. Global Cancer Vaccine Revenue Market Share by Region (2015-2020)
    Figure 16. Global Cancer Vaccine Revenue Market Share by Region in 2019
    Figure 17. Global Cancer Vaccine Sales Share by Manufacturer in 2019
    Figure 18. The Top 10 and 5 Players Market Share by Cancer Vaccine Revenue in 2019
    Figure 19. Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
    Figure 20. Global Cancer Vaccine Sales Market Share by Type (2015-2020)
    Figure 21. Global Cancer Vaccine Sales Market Share by Type in 2019
    Figure 22. Global Cancer Vaccine Revenue Market Share by Type (2015-2020)
    Figure 23. Global Cancer Vaccine Revenue Market Share by Type in 2019
    Figure 24. Global Cancer Vaccine Market Share by Price Range (2015-2020)
    Figure 25. Global Cancer Vaccine Sales Market Share by Application (2015-2020)
    Figure 26. Global Cancer Vaccine Sales Market Share by Application in 2019
    Figure 27. Global Cancer Vaccine Revenue Market Share by Application (2015-2020)
    Figure 28. Global Cancer Vaccine Revenue Market Share by Application in 2019
    Figure 29. China Cancer Vaccine Sales Growth Rate 2015-2026 (MT)
    Figure 30. China Cancer Vaccine Revenue Growth Rate 2015-2026 (US$ Million)
    Figure 31. China Cancer Vaccine Market Share in Global Market 2015-2026
    Figure 32. China 5 and 10 Largest Cancer Vaccine Players Market Share by Revenue in Cancer Vaccine in 2019
    Figure 33. China Cancer Vaccine Revenue Share by Type (2015-2020)
    Figure 34. China Cancer Vaccine Revenue Growth Rate by Type in 2015 & 2019
    Figure 35. China Cancer Vaccine Revenue Share by Application (2015-2020)
    Figure 36. China Cancer Vaccine Revenue Growth Rate by Application in 2015 & 2019
    Figure 37. North America Cancer Vaccine Sales Growth Rate 2015-2020 (MT)
    Figure 38. North America Cancer Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 39. North America Cancer Vaccine Sales Market Share by Country in 2019
    Figure 40. North America Cancer Vaccine Revenue Market Share by Country in 2019
    Figure 41. U.S. Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 42. U.S. Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 43. Canada Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 44. Canada Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 45. Europe Cancer Vaccine Sales Growth Rate 2015-2020 (MT)
    Figure 46. Europe Cancer Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 47. Europe Cancer Vaccine Sales Market Share by Country in 2019
    Figure 48. Europe Cancer Vaccine Revenue Market Share by Country in 2019
    Figure 49. Germany Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 50. Germany Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 51. France Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 52. France Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 53. U.K. Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 54. U.K. Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 55. Italy Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 56. Italy Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 57. Russia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 58. Russia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 59. Asia Pacific Cancer Vaccine Sales Growth Rate 2015-2020 (MT)
    Figure 60. Asia Pacific Cancer Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 61. Asia Pacific Cancer Vaccine Sales Market Share by Region in 2019
    Figure 62. Asia Pacific Cancer Vaccine Revenue Market Share by Region in 2019
    Figure 63. China Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 64. China Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 65. Japan Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 66. Japan Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 67. South Korea Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 68. South Korea Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 69. India Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 70. India Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 71. Australia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 72. Australia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 73. Taiwan Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 74. Taiwan Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 75. Indonesia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 76. Indonesia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 77. Thailand Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 78. Thailand Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 79. Malaysia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 80. Malaysia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 81. Philippines Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 82. Philippines Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 83. Vietnam Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 84. Vietnam Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 85. Latin America Cancer Vaccine Sales Growth Rate 2015-2020 (MT)
    Figure 86. Latin America Cancer Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 87. Latin America Cancer Vaccine Sales Market Share by Country in 2019
    Figure 88. Latin America Cancer Vaccine Revenue Market Share by Country in 2019
    Figure 89. Mexico Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 90. Mexico Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 91. Brazil Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 92. Brazil Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 93. Argentina Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 94. Argentina Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 95. Middle East and Africa Cancer Vaccine Sales Growth Rate 2015-2020 (MT)
    Figure 96. Middle East and Africa Cancer Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
    Figure 97. Middle East and Africa Cancer Vaccine Sales Market Share by Country in 2019
    Figure 98. Middle East and Africa Cancer Vaccine Revenue Market Share by Country in 2019
    Figure 99. Turkey Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 100. Turkey Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 101. Saudi Arabia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 102. Saudi Arabia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 103. U.A.E Cancer Vaccine Sales Growth Rate (2015-2020) (MT)
    Figure 104. U.A.E Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 105. Porter's Five Forces Analysis
    Figure 106. Cancer Vaccine Value Chain
    Figure 107. Channels of Distribution
    Figure 108. Distributors Profiles
    Figure 109. Bottom-up and Top-down Approaches for This Report
    Figure 110. Data Triangulation
    Figure 111. Key Executives Interviewed
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global and China Familial Adenomatous Polyposis Treatment Market Insights Forecast to 2026
Global and China Familial Adenomatous Polyposis Treatment Market Insights, Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-2E3933
Tue Oct 27 00:00:00 UTC 2020

Add to Cart

Global and China Burkitt Lymphoma Treatment Market Size Status and Forecast 2020 2026
Global and China Burkitt Lymphoma Treatment Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-33I3316
Tue Oct 27 00:00:00 UTC 2020

Add to Cart

Global and United States Peptide Based Cancer Therapeutics Market Size Status and Forecast 2020 2026
Global and United States Peptide Based Cancer Therapeutics Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-32Y3446
Tue Oct 27 00:00:00 UTC 2020

Add to Cart

Global and Japan Relapsed Acute Myeloid Leukemia Drug Market Insights Forecast to 2026
Global and Japan Relapsed Acute Myeloid Leukemia Drug Market Insights, Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-4P3638
Tue Oct 27 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0